SCHEMBL8537338

SCHEMBL8537338

CCCCCc1[nH]c2ccccc2c(=O)c1C

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 3/20 0.66
KDM4E B2RXH2 4/20 0.56
ALDH1A1 P00352 4/20 0.56
HPGD P15428 4/20 0.56
HSD17B10 Q99714 4/20 0.56
GAA P10253 2/20 0.56
RAB9A P51151 2/20 0.54
CTSV O60911 3/20 0.54
CTSL P07711 3/20 0.54
OXER1 Q8TDS5 1/20 0.51
HTT P42858 2/20 0.49
TSHR P16473 1/20 0.47
NPC1 O15118 2/20 0.46
CYP1A2 P05177 1/20 0.46
CYP2C19 P33261 1/20 0.46
MCL1 Q07820 1/20 0.46
LMNA P02545 1/20 0.46
GLA P06280 1/20 0.46
ATM Q13315 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12891618 0.98 CYP2D6 (0.68) CYP2D6KDM4EALDH1A1HPGDHSD17B10
SCHEMBL27921144 0.98 CYP2D6 (0.68) CYP2D6KDM4EALDH1A1HPGDHSD17B10
SCHEMBL17400300 0.98 CYP2D6 (0.68) CYP2D6KDM4EALDH1A1HPGDHSD17B10
SCHEMBL27902363 0.98 CYP2D6 (0.68) CYP2D6KDM4EALDH1A1HPGDHSD17B10
SCHEMBL6330362 0.87 OXER1 (0.56) CYP2D6KDM4EALDH1A1HPGDHSD17B10
SCHEMBL3103628 0.87 KDM4E (0.51) CYP2D6KDM4EALDH1A1HPGDHSD17B10
SCHEMBL21555486 0.84 CYP2D6 (0.55) CYP2D6KDM4EALDH1A1HPGDHSD17B10
SCHEMBL14574432 0.84 CYP2D6 (0.51) CYP2D6KDM4EALDH1A1HPGDHSD17B10
SCHEMBL170077 0.84 KDM4E (0.62) CYP2D6KDM4EALDH1A1HPGDHSD17B10
SCHEMBL20030409 0.83 CYP2D6 (0.51) CYP2D6KDM4EALDH1A1HPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11421223-B2 Processes and host cells for genome, pathway, and biomolecular engineering ENEVOLV, INC. (US) 2022-08-23 US disclosed
US-20190309289-A1 PROCESSES AND HOST CELLS FOR GENOME, PATHWAY, AND BIOMOLECULAR ENGINEERING ENEVOLV, INC. 2019-10-10 US disclosed
US-10370654-B2 Processes and host cells for genome, pathway, and biomolecular engineering ENEVOLV, INC. (US) 2019-08-06 US disclosed
US-20180320170-A1 PROCESSES AND HOST CELLS FOR GENOME, PATHWAY, AND BIOMOLECULAR ENGINEERING ENEVOLV, INC. 2018-11-08 US disclosed
US-9944925-B2 Processes and host cells for genome, pathway, and biomolecular engineering ENEVOLV, INC. 2018-04-17 US disclosed
US-20160186168-A1 PROCESSES AND HOST CELLS FOR GENOME, PATHWAY, AND BIOMOLECULAR ENGINEERING ENEVOLV, INC. 2016-06-30 US disclosed
WO-1999031096-A1 PIPERAZINE DERIVATIVES USEFUL AS HYPOGLYCEMIC AGENTS SHAMAN PHARMACEUTICALS, INC. (US) 1999-06-24 WO disclosed